Literature DB >> 6496400

Immunologic abnormalities and their significance in sinus histiocytosis with massive lymphadenopathy.

E Foucar, J Rosai, R F Dorfman, J M Eyman.   

Abstract

In a computerized case registry, containing 220 cases of sinus histiocytosis with massive lymphadenopathy (SHML), 23 patients were identified with clinical or routine laboratory findings suggestive or diagnostic of immune dysfunction. We divided the abnormalities into hematologic autoantibodies (nine patients), glomerulonephritis (three patients), Wiskott-Aldrich syndrome (two patients), joint disease (nine patients), unusual infections (three patients), and miscellaneous (six patients). Nine of the patients had more than one finding prompting inclusion in this study. In five patients, at least one abnormality preceded the onset of SHML. A major difference between this subgroup of 23 patients and the remaining registry population was the mortality rate. Ten of the 23 patients have died, and in many cases the cause of death could be linked to the immunologic abnormality. This study establishes an association between SHML and clinically significant immune dysfunction and provides further evidence that this frequently multisystemic disease may be one manifestation of disordered immunity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6496400     DOI: 10.1093/ajcp/82.5.515

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  13 in total

1.  Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): clinico-pathological study of three cases.

Authors:  Mercedes Bernácer-Borja; Miriam Blanco-Rodríguez; Jose Manuel Sanchez-Granados; Rocío Benitez-Fuentes; Alicia Cazorla-Jimenez; Carmen Rivas-Manga
Journal:  Eur J Pediatr       Date:  2006-04-19       Impact factor: 3.183

2.  Sinus histiocytosis with massive lymphadenopathy and giant cell hepatitis. An unreported association.

Authors:  Dimas Suarez-Vilela; Francisco Miguel Izquierdo-Garcia; José Luis Olcoz-Goñi
Journal:  Virchows Arch       Date:  2003-11-18       Impact factor: 4.064

3.  Sinus histiocytosis with massive lymphadenopathy: complicated by autoimmune hemolytic anemia.

Authors:  Penukonda Sasi Kiran; Vasantha Prema Sowdi; Sumanth B Shetty; U Venugopal; S Parameshwariah; Edwin Dias; C S Kamala
Journal:  Indian J Pediatr       Date:  2003-09       Impact factor: 1.967

Review 4.  Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).

Authors:  W H McAlister; T Herman; L P Dehner
Journal:  Pediatr Radiol       Date:  1990

5.  Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.

Authors:  Sofia Garces; L Jeffrey Medeiros; Keyur P Patel; Shaoying Li; Sergio Pina-Oviedo; Jingyi Li; Juan C Garces; Joseph D Khoury; C Cameron Yin
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

6.  A rare case of "rosai-dorfman disease".

Authors:  K P Basavaraju; D Chandrika; A M Mallikarjunappa; K B Chandrappa; Rahul Wadhwa
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-06-27

Review 7.  Isolated intracranial Rosai-Dorfman disease in a child, a case report and review of the literature.

Authors:  E C Maratos; L R Bridges; A D MacKinnon; J B Madigan; A Atra; A J Martin
Journal:  Childs Nerv Syst       Date:  2014-05-27       Impact factor: 1.475

8.  Cystoid macular oedema associated with Rosai-Dorfman disease: a case report.

Authors:  Rubens Camargo Siqueira; Antonio Augusto Velasco E Cruz
Journal:  BMC Ophthalmol       Date:  2017-08-14       Impact factor: 2.209

9.  Rosai Dorfman Disease presenting as unilateral chronic parotitis.

Authors:  Jk Byrd; Lj Overton; Ta Goldin; Ej Lentsch
Journal:  J Surg Case Rep       Date:  2012-06-01

10.  Rosai-Dorfman disease with paravertebral and epidural thoracic spine involvement: A case report and literature review.

Authors:  Abhilash Jayaram; Nasser Jassim Al Maslamani; Nazeer Ahamad Puthiyaveetil Abdul Rahiman; Vidya Chander Negi
Journal:  Radiol Case Rep       Date:  2020-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.